CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 135 filers reported holding CARA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | -14.8% | 1,440 | -1.7% | 0.01% | -16.7% |
| Q3 2019 | $27,000 | -12.9% | 1,465 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $31,000 | +6.9% | 1,465 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $29,000 | +52.6% | 1,465 | 0.0% | 0.01% | +33.3% |
| Q4 2018 | $19,000 | -45.7% | 1,465 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $35,000 | +25.0% | 1,465 | 0.0% | 0.01% | +27.3% |
| Q2 2018 | $28,000 | +55.6% | 1,465 | +1.7% | 0.01% | +37.5% |
| Q1 2018 | $18,000 | 0.0% | 1,440 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $18,000 | -10.0% | 1,440 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $20,000 | -9.1% | 1,440 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $22,000 | -15.4% | 1,440 | 0.0% | 0.01% | -25.0% |
| Q1 2017 | $26,000 | +100.0% | 1,440 | 0.0% | 0.01% | +71.4% |
| Q4 2016 | $13,000 | +8.3% | 1,440 | 0.0% | 0.01% | +16.7% |
| Q3 2016 | $12,000 | – | 1,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
| Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
| Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
| Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
| PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |